September 20, 2021
This study is for patients with pancreatic cancer that has been surgically removed and has a BRCA1, BRCA2, or PALB2 mutation
September 20, 2021
The study will assess if PET/CT scans can help identify patients who may have better outcomes from adding customized therapy to standard-of-care treatment
February 12, 2020
The TAILORx trial answers questions about when to use chemotherapy to treat the most common type of breast cancer.